Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "LTS"


3 mentions found


Allegations that Gutierrez and other executives were involved in accounting fraud were first made in June. Several former Americanas directors have testified before the congressional committee in the past few weeks. LTS said his comments "do not provide any proof of his allegations or refute evidence of his participation in the fraud". The holding company described what happened at Americanas as "cunning fraud". ($1 = 4.9373 reais)Reporting by Carolina Pulice Editing by Edwina Gibbs and David GoodmanOur Standards: The Thomson Reuters Trust Principles.
Persons: Miguel Gutierrez, Gutierrez, Americanas, Jorge Paulo Lemann, Carlos Alberto Sicupira, Marcel Telles, LTS, Sergio Rial, Edwina Gibbs, David Goodman Organizations: Reuters, Carolina, Thomson Locations: Americanas
Feb 27 (Reuters) - Bath & Body Works Inc (BBWI.N) said on Monday investor Third Point's potential proxy contest is misguided and is a result of the specialty retailer not willing to appoint the hedge fund's former co-chief investment officer to its board. Bath & Body Works said in the last twelve months the board has appointed four highly qualified directors, of which Lucy Brady, a senior executive at Conagra Brands (CAG.N), was proposed by Third Point. In a letter to its shareholders, the company said the potential proxy contest was due to the board's unwillingness to appoint Loeb's former partner Munib Islam to the board. Islam, who played a key role in Third Point's activist campaigns, left the firm in 2020 and is now a senior executive at LTS One, an investment partnership. While it has taken "reasonable" steps to avoid a proxy fight, Bath & Body Works said it is "disappointing and unfortunate" that it will have to spend more time on this despite efforts to engage productively with the hedge fund.
But I think this Club stock has broken away from the pack. Wells Fargo cuts price target on Goldman Sachs (GS) to $390 per share from $400 after Tuesday's earnings disappointment. UBS cuts price target on UnitedHealth (UNH) to $550 per share from $590 after a largely solid quarter; keeps neutral (hold) rating. Analysts also reiterated their $185-per-share price target on the Club stock, which represents over 38% upside from Tuesday's close. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade.
Total: 3